Paylocity (NASDAQ: PCTY) chair sells 15K shares after equity grants
Rhea-AI Filing Summary
For Paylocity Holding Corp (PCTY), Executive Chairman Steven R. Beauchamp reported both equity awards and share sales. On August 14, 2026 he received 3,469 market stock units (MSUs), plus grants of 10,201 restricted stock units vesting over four years and 6,094 restricted stock units vesting over two years. He also received 7,229 performance stock units (PSUs) whose vesting from 2026 to 2028–2029 depends on total shareholder return goals. The same day, he sold a total of 15,000 shares of common stock in multiple transactions at weighted average prices between about $146.74 and $151.34, conducted under a pre-arranged Rule 10b5-1 trading plan. Indirect holdings include shares held by the IRIE Family Trust, SRB 2025 GRAT, IRIE Foundation, and Gotham Triple Advantage Strategy LP.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Market Stock Units F10, F11, F12, F13 | 3,469 | $0.00 | $0.00 |
| Grant/Award | Common Stock, par value $0.001 F1 | 10,201 | $0.00 | $0.00 |
| Grant/Award | Common Stock, par value $0.001 F2 | 6,094 | $0.00 | $0.00 |
| Grant/Award | Common Stock, par value $0.001 F3 | 7,229 | $0.00 | $0.00 |
| Sale | Common Stock, par value $0.001 F4, F5 | 1,200 | $147.23 | $177K |
| Sale | Common Stock, par value $0.001 F4, F6 | 10,569 | $148.46 | $1.57M |
| Sale | Common Stock, par value $0.001 F4, F7 | 3,031 | $149.11 | $452K |
| Sale | Common Stock, par value $0.001 F4, F8 | 156 | $150.58 | $23K |
| Sale | Common Stock, par value $0.001 F4, F9 | 44 | $151.34 | $7K |
| holding | Common Stock, par value $0.001 | -- | -- | -- |
| holding | Common Stock, par value $0.001 | -- | -- | -- |
| holding | Common Stock, par value $0.001 | -- | -- | -- |
| holding | Common Stock, par value $0.001 | -- | -- | -- |
Footnotes (13)
- F1. Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of Common Stock per RSU. The RSUs will vest over four years beginning on the date of grant at a rate of 6.25% vesting every three months. The grant will be settled pursuant to the terms of the Issuer's Amended and Restated 2023 Equity Incentive Plan.
- F2. Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of Common Stock per RSU. The RSUs will vest over two years beginning on the date of grant at a rate of 12.5% vesting every three months. The grant will be settled pursuant to the terms of the Issuer's Amended and Restated 2023 Equity Incentive Plan.
- F3. Represents performance stock units (PSUs) awarded pursuant to the Issuer's Amended and Restated 2023 Equity Incentive Plan for which performance criteria have been satisfied that will entitle the Reporting Person to receive one share of the Issuer's common stock per PSU upon vesting. 50% of the PSUs vest on August 15, 2026. The remaining PSUs will vest in two equal installments on August 15, 2027 and August 15, 2028, subject to continued service through each of the respective vesting dates. The grant will be settled pursuant to the terms of the Issuer's Amended and Restated 2023 Equity Incentive Plan.
- F4. The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on August 19, 2025 and amended on May 15, 2026.
- F5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $146.74 to $147.73, inclusive. The reporting person undertakes to provide to Paylocity Holding Corporation, any security holder of Paylocity Holding Corporation, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 5, 6, 7, 8 and 9 of this Form 4.
- F6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $147.83 to $148.83, inclusive.
- F7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $148.84 to $149.71, inclusive.
- F8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.24 to $151.13, inclusive.
- F9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.33 to $151.34, inclusive.
- F10. Each market stock unit (MSU) represents the contingent right to receive one (1) share of Issuer common stock.
- F11. Reflects the grant of a target number MSUs subject to the award as presented in the table. The number of MSUs that ultimately vest may be 0%-200% of this number, depending upon the achievement by the Issuer of certain total shareholder return objectives.
- F12. The MSUs have four separate performance periods, which begin August 31, 2026 and end November 30, 2028, February 28, 2029, May 31, 2029 and August 31, 2029, respectively. Twenty five percent (25%) of the total award may be earned after the end of each performance period and, to the extent earned, will vest quarterly.
- F13. Market stock units do not expire; they either vest or are canceled prior to or upon the vesting date.
Key Figures
Key Terms
restricted stock units (RSUs) financial
performance stock units (PSUs) financial
market stock units (MSUs) financial
Rule 10b5-1 Plan regulatory
Equity Incentive Plan financial
FAQ
What new equity awards did PCTY grant to Steven Beauchamp on August 14, 2026?
How do the new PCTY RSU awards to Steven Beauchamp vest over time?
What are the terms of Steven Beauchamp’s new PCTY performance stock units (PSUs)?
How do Steven Beauchamp’s new PCTY market stock units (MSUs) work?
AI-generated analysis. How Rhea-AI works. Not financial advice.